Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety
Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety
Recruiting · NCT07216014 · Registry updated 2026-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 4 | 2026-04-24 | NCT07216014 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sixth Affiliated Hospital, Sun Yat-sen University | 122 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| the Sixth Affiliated Hospital of Sun Yat-sen University | Guangzhou | China | 3 |